News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Hutchison China MediTech (Chi-Med) Puts Radiation Drug on Hold


2/5/2009 3:07:35 PM

January 14, 2009 -- Hutchison China MediTech Limited, also known as Chi-Med, has put its radiation sensitizer, HMPL-002, on clinical hold because the drug did not provide a clear clinical advantage. The data came from a Phase II proof-of-concept trial, conducted in China, in patients with stage III non-small cell lung cancer. HMPL-002 was administered in addition to standard chemo-radiotherapy and compared to the standard treatment. More details...

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES